Aviva PLC Organon & Co. Transaction History

Aviva PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$21.42 - $32.08 $538,734 - $806,844	-25,151 Reduced 71.9%	9,829 $231,000
Q4 2022 Feb 09, 2023	SELL	$23.31 - $28.61 $8,275 - $10,156	-355 Reduced 1.0%	34,980 $977,000
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $14,320 - $20,961	-612 Reduced 1.7%	35,335 $827,000
Q2 2022 Aug 04, 2022	SELL	$31.66 - $38.9 $352,565 - $433,190	-11,136 Reduced 23.65%	35,947 $1.21 Million
Q1 2022 May 13, 2022	SELL	$30.45 - $39.36 $1.64 Million - $2.12 Million	-53,789 Reduced 53.32%	47,083 $1.65 Million
Q4 2021 Feb 10, 2022	SELL	$28.67 - $37.13 $684,209 - $886,107	-23,865 Reduced 19.13%	100,872 $3.07 Million
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $372,504 - $463,712	-13,011 Reduced 9.45%	124,737 $4.09 Million
Q2 2021 Aug 10, 2021	BUY	$28.45 - $38.0 $3.92 Million - $5.23 Million	137,748 New	137,748 $4.17 Million

792

203M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.